GlobeNewswire by notified

Continued good sales and earnings performance

Share

Overall, good demand so far but with large variations.Return to normal delivery times.

  •  Sales rose by 23.2% to SEK 34,993 (SEK 28,404) million
  •  Profit after net financial items amounted to SEK 4,953 (3,904) million. Profit after net financial items in the previous year was boosted by non-recurring gains of SEK 118 million: 
    SEK -114 million in Q1 and SEK +232 million in Q2
  •  Earnings per share amounted to SEK 1.89 (SEK 1.48)
  •  Acquisitions of Miles Industries of Canada, Climate for Life of the Netherlands, Solzaima of Portugal and Ceramicx of Ireland 

Overall, growth in demand has been good, but there are large variations between markets and product segments. Our strong position in the property refurbishment market as well as product segments focusing on sustainable energy solutions gives us a robust profile even in the current, weaker economic environment, which primarily affects new production of housing and related product segments,”said Gerteric Lindquist, Managing Director and CEO of NIBE.

“The improvement in the components supply chain that could be seen towards the end of the first half of the year continued in the third quarter, enabling us to bring our own delivery times back to normal levels.” 

”The acquisitions completed in the period will also expand our market presence and give us new product offerings and good insights into new business models.”

”Even though it is difficult to make predictions in the current business climate, we are cautiously optimistic about our full-year performance in 2023 thanks to our geographic spread, our focus on energy efficiency and sustainability, as well as our stable profitability and good financial preparedness for further offensive acquisitions,” said Gerteric Lindquist.

Press information
A media and analysts webcast (in English) will take place today at 11:00 CET with CEO Gerteric Lindquist and CFO Hans Backman. 
NB: Registration on our website www.nibe.com is required in order to participate in the conference and to obtain a code to be able to ask questions.

For more information: Gerteric Lindquist, CEO, and Hans Backman, CFO: +46 (0)433 27 30 00

NIBE Industrier AB (publ) is required to disclose the information in this press release under the EU’s Market Abuse Regulation and the Swedish Securities Market Act. This information was submitted by the contact persons above for publication on November 15, 2023 at 08:00 CET. 

NIBE Group – an international organization with companies and a presence worldwide
The NIBE Group is an international Group that contributes to a reduced carbon footprint and better utilization of energy. In our three business areas – Climate Solutions, Element and Stoves – we develop, manufacture and market 
a wide range of eco-friendly, energy-efficient solutions for indoor climate comfort in all types of properties, plus components and solutions for intelligent heating and control in industry and infrastructure. 

Since its beginnings in the town of Markaryd in the Swedish province of Småland 70 years ago, NIBE has grown into an international company with an average of 21,300 (20,400) employees and an international presence. From the very start, the company has been driven by a strong culture of entrepreneurship and a passion for corporate responsibility. Its success factors are long-term investments in sustainable product development and strategic acquisitions. Combined, these factors have brought about strong, targeted growth, which generated sales of just over SEK 40 (30) billion in 2022. 

NIBE has been listed under the name NIBE Industrier AB on the Nasdaq Nordic Large Cap list since 1997, with a secondary listing on the SIX Swiss Exchange since 2011.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Azerion publishes Interim Unaudited Financial Results Q4 2023 and Preliminary Unaudited Financial Results Full Year 202328.2.2024 07:15:00 CET | Press release

Platform growth and improved efficiency driving performance in Q4 Highlights of Q4 2023 Net revenue of € 171.8 million, up 15.5% from € 148.8 million in Q4 2022, mainly driven by Platform Segment growth, particularly in advertising revenue from Direct sales, e-commerce and previous acquisitions including Hawk. Adjusted EBITDA of € 25.9 million, up 17.2% from € 22.1 million in Q4 2022 with margins improved due to increased Platform Segment revenue and contribution from Direct sales, continued integration of previous acquisitions and ongoing cost optimisation. Platform segment Adjusted EBITDA, of € 22.3 million, up 26.0% compared to € 17.7 million in Q4 2022, reflecting increased Net revenue and Platform efficiencies from optimisation and consolidation efforts. Increased the average digital ads sold per month by over 20% to approximately 12.9 billion in Q4 2023, up from approximately 10.7 billion in Q4 2022, driven by the integration of past acquisitions and the increased cross-selling o

Strong data from DSR® proof-of-concept studies in heart failure accepted for late-breaking presentation at THT 202428.2.2024 07:00:00 CET | Press release

Presentation by Key Opinion Leader Dr. Testani on Wednesday, March 6th 2024 Ghent, Belgium – 28 February 2024– Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "SequanaMedical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today announces that the late-breaking abstract including data from the RED DESERT and SAHARA proof-of-concept studies of the Company’s DSR therapy in patients with diuretic-resistant heart failure have been selected for a late-breaking presentation at THT 2024. Technology and Heart failure Therapeutics (THT) will be held from March 4th to 6th, 2024 in Boston, US and is an international conference on the latest heart failure innovations, focusing on device- and technology-based treatments within the context of drug therapies. The abstract “Serial Direct Sodium Removal in Patients with Heart Failure and Diuretic Resistance” will be presented on Wednesday March 6th, 2024 by Dr. Jeffrey Testani, Associate Profe

12/2024・Trifork Holding AG – 2023 annual report and interim report for the quarter ending 31 December 202328.2.2024 07:00:00 CET | Press release

Trifork Holding AG Annual Financial Report Trifork Group – 2023 annual report and interim report for the quarter ending 31 December 2023 Company announcement no. 12 / 2024 Schindellegi, Switzerland – 28 February 2024 Trifork Group reports revenue growth of 12.4%for 2023 and 10.4% in Q4 2023 Full-year 2023 Trifork Group In 2023, Trifork Group revenue amounted to EURm 207.9, an increase of 12.4% from 2022. Organic growth was 9.3% driven by good activity in Digital Health, Smart Enterprise, Smart Building, and Cloud Operations. Inorganic growth of 3.1% came from the acquisitions of IBE and Chapter 5.Trifork Group EBITDA amounted to EURm 33.2, corresponding to 16.0% EBITDA margin.Trifork Group EBIT amounted to EURm 19.7, corresponding to 9.5% EBIT margin.Trifork Group net income amounted to EURm 17.4. Positive fair value adjustments in Trifork Labs of EURm 6.9 contributed to net income.Trifork Segment In 2023, adjusted EBITDA of the Trifork segment amounted to EURm 35.0, an increase of 9.7

Charlotte Hanneman to succeed Abhijit Bhattacharya as Philips’ Chief Financial Officer (CFO)28.2.2024 07:00:00 CET | Press release

February 28, 2024 Proposal to appoint Ms. Hanneman as member of Philips’ Board of Management fulfilling the role of CFO per October 1, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the proposal to appoint Charlotte Hanneman as member of the Board of Management, fulfilling the role of Chief Financial Officer (CFO), effective October 1, 2024. The proposal will be submitted to the Annual General Meeting of Shareholders (AGM), to be held on May 7, 2024. Ms. Hanneman will join Philips as a member of Philips’ Executive Committee on June 1, 2024, to start her induction and transition into the role, succeeding current CFO Abhijit Bhattacharya on October 1, 2024. Mr. Bhattacharya has been CFO and member of Philips’ Board of Management and Executive Committee since 2015 and will retire from the company after a successful 37-year career on September 30, 2024. Ms. Hanneman (Dutch, 1978) will join Philips with over 20 y

Idorsia and Viatris enter into a significant global research and development collaboration28.2.2024 07:00:00 CET | Press release

Ad hoc announcement pursuant to Art. 53 LR Viatris and Idorsia will collaborate on the global development and commercialization of two Phase 3 assets, selatogrel and cenerimod.Idorsia to receive an upfront payment of USD 350 million, potential development and regulatory milestone payments, additional sales milestone payments and tiered royalties on annual net sales.Viatris and Idorsia will both contribute to the development costs for both programs.Includes future optionality to expand collaboration with additional pipeline assets.Combines Viatris’ financial strength and worldwide operational infrastructure with Idorsia’s proven, highly productive drug development team and innovative engine. Allschwil, Switzerland – February 28, 2024 Idorsia Ltd (SIX: IDIA) today announced that it has entered into agreements for a significant global research and development collaboration with Viatris Inc. (NASDAQ: VTRS), a global healthcare company, for the global development and commercialization of tw

HiddenA line styled icon from Orion Icon Library.Eye